Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04590729 · ClinicalTrials.gov registry record · NA
Interrupting Sitting Time During Postprandial State
A NA study, sponsored by Franklin Pierce University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04590729: Completed NA study, sponsored by Franklin Pierce University.
NCT04590729 is a NA study that has completed, run by Franklin Pierce University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04590729, a NA study, has completed, sponsored by Franklin Pierce University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The literature has shown that interrupting sitting time with frequent physical activities (e.g., cycling on a stationary bike for 3 minutes every 30 minutes of sitting) is effective for decreasing blood sugar levels. However, the optimal frequency and distribution of sitting interruption remains less clear. The purpose of this study is to compare the effects of two different protocols of sitting interruption (i.e., 3 minutes of cycling every 30 minutes versus 3 minutes of cycling every 15 minutes) on blood sugar levels.
Primary Outcome
The investigators will measure capillary blood sugar levels every 30 minutes using the finger-stick method.
Interventions
- BEHAVIORAL 3-min Exercise Per 30 Min
- BEHAVIORAL 3-min Exercise Per 15 Min
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2020-11-20 |
| Phase | NA |
What the finished NCT04590729 record still lists
NCT04590729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which 3-min Exercise Per 30 Min is the first listed.
NCT04590729 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04590729 about?
NCT04590729 is a clinical study titled "Interrupting Sitting Time During Postprandial State". The literature has shown that interrupting sitting time with frequent physical activities (e.g., cycling on a stationary bike for 3 minutes every 30 minutes of sitting) is effective for decreasing blood sugar levels. However, the optimal frequency and distribution of sitting interruption remains les...
What is the current status of trial NCT04590729?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2020-10-20. Estimated completion is 2020-11-20.
What interventions are being tested in trial NCT04590729?
The interventions under investigation include: 3-min Exercise Per 30 Min (BEHAVIORAL), 3-min Exercise Per 15 Min (BEHAVIORAL).
Who is sponsoring clinical trial NCT04590729?
This trial is sponsored by Franklin Pierce University, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04590729's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI